117 related articles for article (PubMed ID: 1381610)
1. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors.
Yamamoto N; Akamatsu N; Yamazaki H; Tanoue K
Br J Haematol; 1992 May; 81(1):86-92. PubMed ID: 1381610
[TBL] [Abstract][Full Text] [Related]
2. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36).
Yamamoto N; Ikeda H; Tandon NN; Herman J; Tomiyama Y; Mitani T; Sekiguchi S; Lipsky R; Kralisz U; Jamieson GA
Blood; 1990 Nov; 76(9):1698-703. PubMed ID: 1699620
[TBL] [Abstract][Full Text] [Related]
3. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.
Tandon NN; Kralisz U; Jamieson GA
J Biol Chem; 1989 May; 264(13):7576-83. PubMed ID: 2468670
[TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes.
Yamamoto N; Akamatsu N; Sakuraba H; Yamazaki H; Tanoue K
Blood; 1994 Jan; 83(2):392-7. PubMed ID: 7506948
[TBL] [Abstract][Full Text] [Related]
5. Expression of GPIV and N(aka) antigen on monocytes in N(aka)-negative subjects whose platelets lack GPIV.
Take H; Kashiwagi H; Tomiyama Y; Honda S; Honda Y; Mizutani H; Furubayashi T; Karasuno T; Nishiura T; Kanayama Y
Br J Haematol; 1993 Jul; 84(3):387-91. PubMed ID: 7692927
[TBL] [Abstract][Full Text] [Related]
6. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression.
Aiken ML; Ginsberg MH; Byers-Ward V; Plow EF
Blood; 1990 Dec; 76(12):2501-9. PubMed ID: 1702328
[TBL] [Abstract][Full Text] [Related]
7. Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V.
Kehrel B; Kronenberg A; Rauterberg J; Niesing-Bresch D; Niehues U; Kardoeus J; Schwippert B; Tschöpe D; van de Loo J; Clemetson KJ
Blood; 1993 Dec; 82(11):3364-70. PubMed ID: 7694682
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation results in a redistribution of glycoprotein IV (CD36).
Michelson AD; Wencel-Drake JD; Kestin AS; Barnard MR
Arterioscler Thromb; 1994 Jul; 14(7):1193-201. PubMed ID: 7517184
[TBL] [Abstract][Full Text] [Related]
9. Platelet adhesion to collagen in individuals lacking glycoprotein IV.
McKeown L; Vail M; Williams S; Kramer W; Hansmann K; Gralnick H
Blood; 1994 May; 83(10):2866-71. PubMed ID: 7514049
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 IgM monoclonal antibody NL07.
Alessio M; Greco NJ; Primo L; Ghigo D; Bosia A; Tandon NN; Ockenhouse CF; Jamieson GA; Malavasi F
Blood; 1993 Dec; 82(12):3637-47. PubMed ID: 7505121
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction.
Beer JH; Rabaglio M; Berchtold P; von Felten A; Clemetson KJ; Tsakiris DA; Kehrel B; Brandenberger S
Blood; 1993 Aug; 82(3):820-9. PubMed ID: 7687896
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin promotes platelet aggregation.
Tuszynski GP; Rothman VL; Murphy A; Siegler K; Knudsen KA
Blood; 1988 Jul; 72(1):109-15. PubMed ID: 3390605
[TBL] [Abstract][Full Text] [Related]
13. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
[TBL] [Abstract][Full Text] [Related]
14. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin binds normally to glycoprotein IIIb deficient platelets.
Kehrel B; Kronenberg A; Schwippert B; Niesing-Bresch D; Niehues U; Tschöpe D; van de Loo J; Clemetson KJ
Biochem Biophys Res Commun; 1991 Sep; 179(2):985-91. PubMed ID: 1716890
[TBL] [Abstract][Full Text] [Related]
17. Whole blood platelet aggregation in humans and animals: a comparative study.
Soloviev MV; Okazaki Y; Harasaki H
J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
[TBL] [Abstract][Full Text] [Related]
18. Dauricine inhibits redistribution of platelet membrane glycoprotein IV and release of intracellular alpha-granule thrombospondin induced by thrombin.
Guo T; Zhang YZ; Liu DX; Zou P; Shen D
Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):533-6. PubMed ID: 10678148
[TBL] [Abstract][Full Text] [Related]
19. Role of thrombospondin in platelet aggregation.
Leung LL
J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
[TBL] [Abstract][Full Text] [Related]
20. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood.
Diaz-Ricart M; Tandon NN; Carretero M; Ordinas A; Bastida E; Jamieson GA
Blood; 1993 Jul; 82(2):491-6. PubMed ID: 7687161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
